Clinical Scorecard: Insights on Key Factors Influencing Post-Stroke Depression and Cognitive Decline in Survivors of Acute Stroke

At a Glance

Key Highlights

• Right-hemisphere lesions, higher baseline PHQ-9 scores, and lower baseline MMSE scores predict post-stroke outcomes.
• Post-stroke depression (PSD) and cognitive impairment (PSCI) often co-occur and share neurobiological substrates.
• Screening for PSD using PHQ-9 and cognitive assessment with MMSE and MoCA are essential in acute stroke care.
• Lower baseline MMSE scores may indicate pre-existing cognitive vulnerability.
• Future research should focus on integrating neuropsychiatric assessments into stroke care pathways.

Guideline-Based Recommendations

Diagnosis

• Use DSM-5 criteria for diagnosing PSD.
• Employ PHQ-9 with a cutoff of ≥5 for initial screening.

Management

• Consider a two-stage screening approach: initial PHQ-2 followed by PHQ-9 for positive screens.

Monitoring & Follow-up

• Monitor for depressive symptoms and cognitive decline during follow-up.

Risks

• Transient post-stroke symptoms may be misclassified as PSD if not properly assessed.

Patient & Prescribing Data

Acute ischemic stroke survivors at risk for PSD and PSCI.

Timely multidisciplinary follow-up is recommended based on PHQ-9 and MMSE results.

Clinical Best Practices

• Incorporate structured mood and cognitive assessments early in post-stroke care.
• Utilize MoCA for a more sensitive detection of cognitive deficits post-stroke.

Related Resources & Content

• Yan et al. (2026)